• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大萨斯喀彻温省用于估计慢性阻塞性肺疾病急性加重相关医疗保健使用情况和费用的分类模型准确性比较:一项回顾性队列研究。

Comparison of the accuracy of classification models to estimate healthcare use and costs associated with COPD exacerbations in Saskatchewan, Canada: A retrospective cohort study.

作者信息

Kuwornu John Paul, Teare Gary F, Quail Jacqueline M, Forget Evelyn, Muthukumarana Saman, Wang Xiaoyun E, Osman Meric, Lix Lisa M

机构信息

Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Saskatchewan Health Quality Council, 111 Research Drive, Saskatoon, SK, Canada.

出版信息

Can J Respir Ther. 2017 Summer;53(3):37-44. Epub 2017 Aug 1.

PMID:30996632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6422214/
Abstract

OBJECTIVE

COPD is a high-cost disease and results in frequent contacts with the healthcare system. The study objective was to compare the accuracy of classification models with different covariates for classifying COPD patients into cost groups.

METHODS

Linked health administrative databases from Saskatchewan, Canada, were used to identify a cohort of newly diagnosed COPD patients (April 1, 2007 to March 31, 2011) and their episodes of healthcare encounters for disease exacerbations. Total costs of the first and follow-up episodes were computed and patients were categorized as persistently high cost, occasionally high cost, and persistently low cost based on cumulative cost distribution ranking using the 75th percentile cutoff for high-cost status. Classification accuracy was compared for seven multinomial logistic regression models containing socio-demographic characteristics (i.e., base model), and socio-demographic and prior healthcare use characteristics (i.e., comparator models).

RESULTS

Of the 1182 patients identified, 8.5% were classified as persistently high cost, 26.1% as occasionally high cost, and the remainder as persistently low cost. The persistently high-cost and occasionally high-cost patients incurred 10 times ($12 449 vs $1263) and seven times ($9334 vs $1263) more costs in their first exacerbation episode than persistently low-cost patients, respectively. Classification accuracy was 0.67 for the base model, whereas the comparator model containing socio-demographic and number of prior hospital admissions had the highest accuracy (0.72).

CONCLUSIONS

Costs associated with COPD exacerbation episodes are substantial. Adding prior hospitalization to socio-demographic characteristics produced the highest improvements in classification accuracy. Accurate classification models are important for identifying potential healthcare cost management strategies.

摘要

目的

慢性阻塞性肺疾病(COPD)是一种高成本疾病,导致患者频繁与医疗保健系统接触。本研究的目的是比较使用不同协变量的分类模型将COPD患者分类到成本组中的准确性。

方法

利用加拿大萨斯喀彻温省的联合卫生行政数据库,确定一组新诊断的COPD患者(2007年4月1日至2011年3月31日)及其疾病加重的医疗接触事件。计算首次和后续事件的总成本,并根据使用第75百分位数作为高成本状态临界值的累积成本分布排名,将患者分为持续高成本、偶尔高成本和持续低成本三类。比较了包含社会人口学特征(即基础模型)以及社会人口学和既往医疗使用特征(即比较模型)的七个多项逻辑回归模型的分类准确性。

结果

在识别出的1182名患者中,8.5%被分类为持续高成本,26.1%为偶尔高成本,其余为持续低成本。在首次加重事件中,持续高成本和偶尔高成本患者分别比持续低成本患者多产生10倍(12449美元对1263美元)和7倍(9334美元对1263美元)的成本。基础模型的分类准确性为0.67,而包含社会人口学特征和既往住院次数的比较模型具有最高的准确性(0.72)。

结论

与COPD加重事件相关的成本很高。在社会人口学特征中加入既往住院史可使分类准确性得到最大程度的提高。准确的分类模型对于确定潜在的医疗成本管理策略很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e42/6422214/e2111a8efdd0/CJRT-53-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e42/6422214/e2111a8efdd0/CJRT-53-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e42/6422214/e2111a8efdd0/CJRT-53-37-g001.jpg

相似文献

1
Comparison of the accuracy of classification models to estimate healthcare use and costs associated with COPD exacerbations in Saskatchewan, Canada: A retrospective cohort study.加拿大萨斯喀彻温省用于估计慢性阻塞性肺疾病急性加重相关医疗保健使用情况和费用的分类模型准确性比较:一项回顾性队列研究。
Can J Respir Ther. 2017 Summer;53(3):37-44. Epub 2017 Aug 1.
2
Identifying Distinct Healthcare Pathways During Episodes of Chronic Obstructive Pulmonary Disease Exacerbations.识别慢性阻塞性肺疾病急性加重期的不同医疗途径。
Medicine (Baltimore). 2016 Mar;95(9):e2888. doi: 10.1097/MD.0000000000002888.
3
A new method for examining the cost savings of reducing COPD exacerbations.一种新方法可用于检验降低 COPD 加重的成本节约。
Pharmacoeconomics. 2010;28(9):733-49. doi: 10.2165/11535600-000000000-00000.
4
Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectives.布地奈德/福莫特罗添加噻托溴铵对比安慰剂添加噻托溴铵用于慢性阻塞性肺疾病患者的成本效果:澳大利亚、加拿大和瑞典的医疗保健观点。
Pharmacoeconomics. 2011 May;29(5):403-14. doi: 10.2165/11590380-000000000-00000.
5
Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis.与 COPD 加重相关的增量第三方成本:一项回顾性索赔分析。
J Med Econ. 2011;14(3):315-23. doi: 10.3111/13696998.2011.576295. Epub 2011 Apr 18.
6
Real-World Cost-Consequence Analysis of an Integrated Chronic Disease Management Program in Saskatchewan, Canada.加拿大萨斯喀彻温省综合慢性病管理项目的真实世界成本效益分析
Health Serv Insights. 2024 Jan 10;17:11786329231224621. doi: 10.1177/11786329231224621. eCollection 2024.
7
[Use of resources and associated costs of chronic obstructive pulmonary disease exacerbations: A population based retrospective study].[慢性阻塞性肺疾病急性加重的资源利用及相关成本:一项基于人群的回顾性研究]
Semergen. 2014 May-Jun;40(4):189-97. doi: 10.1016/j.semerg.2013.10.002. Epub 2014 Jan 30.
8
COPD exacerbation frequency and its association with health care resource utilization and costs.慢性阻塞性肺疾病(COPD)急性加重的频率及其与医疗资源利用和成本的关联。
Int J Chron Obstruct Pulmon Dis. 2015 Dec 3;10:2609-18. doi: 10.2147/COPD.S90148. eCollection 2015.
9
COPD management costs according to the frequency of COPD exacerbations in UK primary care.根据英国初级保健中 COPD 加重的频率来管理 COPD 的成本。
Int J Chron Obstruct Pulmon Dis. 2014;9:65-73. doi: 10.2147/COPD.S54417. Epub 2014 Jan 9.
10
COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.在Humana医疗保险成员中,慢性阻塞性肺疾病(COPD)急性加重与改良的医学研究委员会量表及COPD评估测试的相关性。
Int J Chron Obstruct Pulmon Dis. 2016 Jan 14;11:111-21. doi: 10.2147/COPD.S94323. eCollection 2016.

引用本文的文献

1
An economic evaluation of chronic obstructive pulmonary disease clinical pathway in Saskatchewan, Canada: Data-driven techniques to identify cost-effectiveness among patient subgroups.加拿大萨斯喀彻温省慢性阻塞性肺疾病临床路径的经济评价:在患者亚组中识别成本效益的基于数据的技术。
PLoS One. 2024 Apr 1;19(4):e0301334. doi: 10.1371/journal.pone.0301334. eCollection 2024.
2
Real-World Cost-Consequence Analysis of an Integrated Chronic Disease Management Program in Saskatchewan, Canada.加拿大萨斯喀彻温省综合慢性病管理项目的真实世界成本效益分析
Health Serv Insights. 2024 Jan 10;17:11786329231224621. doi: 10.1177/11786329231224621. eCollection 2024.
3

本文引用的文献

1
Patterns of health care use in a high-cost inpatient population in Ottawa, Ontario: a retrospective observational study.安大略省渥太华高成本住院患者的医疗保健使用模式:一项回顾性观察研究。
CMAJ Open. 2015 Jan 13;3(1):E111-8. doi: 10.9778/cmajo.20140049. eCollection 2015 Jan-Mar.
2
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend.慢性阻塞性肺疾病(COPD)不断上升的成本以及维持治疗减缓这一趋势的潜力。
Am Health Drug Benefits. 2014 Apr;7(2):98-106.
3
Predicting patients with high risk of becoming high-cost healthcare users in Ontario (Canada).
Increasing Prevalence and Direct Health Care Cost of Inflammatory Bowel Disease Among Adults: A Population-Based Study From a Western Canadian Province.
成人炎症性肠病患病率上升及直接医疗费用:来自加拿大西部省份的一项基于人群的研究
J Can Assoc Gastroenterol. 2021 Mar 16;4(6):296-305. doi: 10.1093/jcag/gwab003. eCollection 2021 Dec.
预测安大略省(加拿大)成为高成本医疗保健使用者风险较高的患者。
Healthc Policy. 2014 Feb;9(3):68-79.
4
Quantifying health services use for chronic obstructive pulmonary disease.定量评估慢性阻塞性肺疾病的卫生服务利用。
Am J Respir Crit Care Med. 2013 Mar 15;187(6):596-601. doi: 10.1164/rccm.201211-2044OC. Epub 2013 Jan 17.
5
High cost patients for cardiac surgery and hospital quality in Turkey.土耳其心脏手术的高成本患者和医院质量。
Health Policy. 2013 Feb;109(2):143-9. doi: 10.1016/j.healthpol.2012.09.015. Epub 2012 Oct 22.
6
Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts.比较三种基于人群队列的共病测量指标,以预测死亡率和住院率。
BMC Health Serv Res. 2011 Jun 10;11:146. doi: 10.1186/1472-6963-11-146.
7
Following the money: factors associated with the cost of treating high-cost Medicare beneficiaries.追踪资金:与治疗高费用医疗保险受益人的成本相关的因素。
Health Serv Res. 2011 Aug;46(4):997-1021. doi: 10.1111/j.1475-6773.2011.01242.x. Epub 2011 Feb 9.
8
Bundling acute and postacute payment: from a culture of compliance to a culture of innovation and best practice.捆绑急性和急性后期支付:从合规文化到创新与最佳实践文化。
Phys Ther. 2010 May;90(5):658-62. doi: 10.2522/ptj.2010.90.5.658.
9
Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.1996年至2007年加拿大安大略省慢性阻塞性肺疾病的患病率、发病率和死亡率趋势:一项基于人群的研究。
Arch Intern Med. 2010 Mar 22;170(6):560-5. doi: 10.1001/archinternmed.2010.17.
10
Health care spending and service use among high-cost Medicaid beneficiaries, 2002-2004.2002 - 2004年高成本医疗补助受益人的医疗保健支出与服务使用情况
Inquiry. 2009;46(4):405-17. doi: 10.5034/inquiryjrnl_46.4.405.